Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04638998 · ClinicalTrials.gov registry record
Assessing Neuroinflammation in GWI Using MRS
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 49
- Enrollment target
NCT04638998 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 49 participants.
The verdict
NCT04638998 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine if Gulf War Illness (GWI) likely involves neuroinflammation. The investigators hypothesize that GWI involves neuroinflammation. By assessing the five neuroinflammatory outcomes across the brain, the investigators can determine if there are focal or global signs of one or more neuroinflammatory markers in the brains of individuals with GWI. This neuroimaging technique may allow investigators and others to detect cases of GWI neuroinflammation, which would improve treatment decisions as well as the development of new targeted therapies. It is an ideal diagnostic tool because it has low patient risk, is noninvasive, can be used repeatedly in longitudinal studies, provides whole-brain coverage, yields multiple independent markers of inflammation, and can be employed at most hospitals and research neuroimaging suites.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04638998
The ClinicalTrials.gov registry entry for NCT04638998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT04638998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04638998 about?
NCT04638998 is a clinical study titled "Assessing Neuroinflammation in GWI Using MRS". The primary aim of this study is to determine if Gulf War Illness (GWI) likely involves neuroinflammation. The investigators hypothesize that GWI involves neuroinflammation. By assessing the five neuroinflammatory outcomes across the brain, the investigators can determine if there are focal or globa...
What is the current status of trial NCT04638998?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2020-12-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04638998?
The interventions under investigation include: Blood draw (PROCEDURE), Magnetic Resonance Spectroscopic Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT04638998?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.